Journal Home > Volume 4 , Issue 1

Clinical repair of a nerve defect is one of the most challenging surgical problems. Autologous nerve grafting remains the gold standard treatment in addressing peripheral nerve injuries that cannot be bridged by direct epineural suturing. However, the autologous nerve graft is not readily available, and the process of harvesting autologous nerve graft results in several complications. Thus, it is necessary to explore an alternative to autologous nerve graft. In the last few decades, with significant advances in the life sciences and biotechnology, a lot of artificial nerve grafts have been developed to aim at the treatment of peripheral nerve disruptions. Artificial nerve grafts range from biological tubes to synthetic tubes and from nondegradable tubes to degradable tubes. Among them, acellular nerve allografts and artificial nerve repair conduits are two kinds of the most promising substitutes for nerve autografts. The history, research status, and prospect of acellular nerve allografts and artificial nerve repair conduits are described briefly in this review.


menu
Abstract
Full text
Outline
About this article

Progress of nerve bridges in the treatment of peripheral nerve disruptions

Show Author's information Qiang Ao( )
Department of Tissue Engineering, School of Fundamental Science, China Medical University, Shenyang, Liaoning, Peoples’ Republic of China

Abstract

Clinical repair of a nerve defect is one of the most challenging surgical problems. Autologous nerve grafting remains the gold standard treatment in addressing peripheral nerve injuries that cannot be bridged by direct epineural suturing. However, the autologous nerve graft is not readily available, and the process of harvesting autologous nerve graft results in several complications. Thus, it is necessary to explore an alternative to autologous nerve graft. In the last few decades, with significant advances in the life sciences and biotechnology, a lot of artificial nerve grafts have been developed to aim at the treatment of peripheral nerve disruptions. Artificial nerve grafts range from biological tubes to synthetic tubes and from nondegradable tubes to degradable tubes. Among them, acellular nerve allografts and artificial nerve repair conduits are two kinds of the most promising substitutes for nerve autografts. The history, research status, and prospect of acellular nerve allografts and artificial nerve repair conduits are described briefly in this review.

Keywords: repair, peripheral nerve injury, acellular nerve graft, nerve conduit

References(63)

1.
Nectow AR, Marra KG, Kaplan DL. Biomaterials for the development of peripheral nerve guidance conduits. Tissue Eng Part B Rev. 2011;18(1):40-50.
2.
Taylor CA, Braza D, Rice JB, Dillingham T. The incidence of peripheral nerve injury in extremity trauma. Am J Phys Med Rehabil. 2008;87(5):381-385.
3.
Ducic I, Fu R, Iorio ML. Innovative treatment of peripheral nerve injuries: combined reconstructive concepts. Ann Plast Surg. 2012;68(2):180-187.
4.
Hussain M, Huang W, Priestley J. The regenerative potential of fully-degummed silk conduits in peripheral nerve injury repair compared to the current ‘gold standard’ of autologous graft repair. Int J Surg. 2013;11(8):591-591.
5.
Staniforth P, Fisher TR. The effects of sural nerve excision in autogenous nerve grafting. Hand. 1978;10(2):187-190.
6.
Ortiguela ME, Wood MB, Cahill DR. Anatomy of the sural nerve complex. J Hand Surg Am. 1987;12(6):1119-1123.
7.
Mackinnon SE, Novak CB. Nerve transfers. New options for reconstruction following nerve injury. Hand Clin. 1999;15(4):643-666.
8.
Porayko MK, Textor SC, Krom RA, et al. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc. 1994;69(2):105-111.
9.
Gulati AK. Immunological fate of Schwann cell-populated acellular basal lamina nerve allografts. Transplantation. 1995;59(11):1618-1622.
10.
Ide C, Osawa T, Tohyama K. Nerve regeneration through allogeneic nerve grafts with special reference to the role of the Schwann cell basal lamina. Prog Neurobiol. 1990;34(1):1-38.
11.
Tajima K, Tohyama K, Ide C, Abe M. Regeneration through nerve allografts in the cynomolgus monkey (Macaca fascicularis). J Bone Joint Surg Am. 1991;73(2):172-185.
12.
Hess JR, Brenner MJ, Fox IK, et al. Use of cold-preserved allografts seeded with autologous Schwann cells in the treatment of a long-gap peripheral nerve injury. Plast Reconstr Surg. 2007;119(1):246-259.
13.
Hudson TW, Zawko S, Deister C, et al. Optimized acellular nerve graft is immunologically tolerated and supports regeneration. Tissue Eng. 2004;10(11-12):1641-1651.
14.
Fox IK, Jaramillo A, Hunter DA, Rickman SR, Mohanakumar T, Mackinnon SE. Prolonged cold-preservation of nerve allografts. Muscle Nerve. 2005;31(1):59-69.
15.
Evans PJ, Mac Kinnon SE, Midha R, et al. Regeneration across cold preserved peripheral nerve allografts. Microsurgery. 1999;19(3):115-127.
DOI
16.
Evans PJ, Mackinnon SE, Best TJ, et al. Regeneration across preserved peripheral nerve grafts. Muscle Nerve. 1995;18(10):1128-1138.
17.
Moore AM, Mac Ewan M, Santosa KB, et al. Acellular nerve allografts in peripheral nerve regeneration: a comparative study. Muscle Nerve. 2011;44(2):221-234.
18.
Nadim W, Anderson PN, Turmaine M. The role of Schwann cells and basal lamina tubes in the regeneration of axons through long lengths of freeze-killed nerve grafts. Neuropathol Appl Neurobiol. 1990;16(5):411-421.
19.
Hall SM. The effect of inhibiting Schwann cell mitosis on the re-innervation of acellular autografts in the peripheral nervous system of the mouse. Neuropathol Appl Neurobiol. 1986;12(4):401-414.
20.
Osawa T, Tohyama K, Ide C. Allogeneic nerve grafts in the rat, with special reference to the role of Schwann cell basal laminae in nerve regeneration. J Neurocytol. 1990;19(6):833-849.
21.
Gulati AK, Cole GP. Immunogenicity and regenerative potential of acellular nerve allografts to repair peripheral nerve in rats and rabbits. Acta Neurochir (Wien). 1994;126(2-4):158-164.
22.
Levi AD, Evans PJ, Mackinnon SE, Bunge RP. Cold storage of peripheral nerves: an in vitro assay of cell viability and function. Glia. 1994;10(2):121-131.
23.
Sondell M, Lundborg G, Kanje M. Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res. 1998;795(1-2):44-54.
24.
Evans PJ, Mackinnon SE, Levi AD, et al. Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve. 1998;21(11):1507-1522.
DOI
25.
Strasberg SR, Hertl MC, Mackinnon SE, et al. Peripheral nerve allograft preservation improves regeneration and decreases systemic cyclosporin A requirements. Exp Neurol. 1996;139(2):306-316.
26.
Dumont CE, Hentz VR. Enhancement of axon growth by detergent-extracted nerve grafts. Transplantation. 1997;63(9):1210-1215.
27.
Snow DM, Lemmon V, Carrino DA, Caplan AI, Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol. 1990;109(1):111-130.
28.
Zuo J, Neubauer D, Dyess K, Ferguson TA, Muir D. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol. 1998;154(2):654-662.
29.
Neubauer D, Graham JB, Muir D. Chondroitinase treatment increases the effective length of acellular nerve grafts. Exp Neurol. 2007;207(1):163-170.
30.
Krekoski CA, Neubauer D, Zuo J, Muir D. Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan. J Neurosci. 2001;21(16):6206-6213.
31.
Alilain WJ, Horn KP, Hu H, Dick TE, Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature. 2011;475(7355):196-200.
32.
Roam JL, Yan Y, Nguyen PK, et al. A modular, plasmin-sensitive, clickable poly(ethyleneglycol)-heparin-laminin microsphere system for establishing growth factor gradients in nerve guidance conduits. Biomaterials. 2015;72:112-124.
33.
Dornseifer ULF, Fichter AM, Leichtle S, et al. Peripheral nerve reconstruction with collagen tubes filled with denatured autologous muscle tissue in the rat model. Microsurgery. 2011;31(8):632-641.
34.
Chiu DT, Janecka I, Krizek TJ, Wolff M, Lovelace RE. Autogenous vein graft as a conduit for nerve regeneration. Surgery. 1982;91(2):226-233.
35.
Siemionow M, Demir Y, Mukherjee AL. Repair of peripheral nerve defects with epineural sheath grafts. Ann Plast Surg. 2010;65(6):546-554.
36.
Yuksel F, Ulkur E, Baloglu H, Celikoz B. Nerve regeneration through a healthy peripheral nerve trunk as a nerve conduit: a preliminary study of a new concept in peripheral nerve surgery. Microsurgery. 2002;22(4):138-143.
37.
Tos P, Battiston B, Ciclamini D, Geuna S, Artiaco S. Primary repair of crush nerve injuries by means of biological tubulization with muscle-vein-combined grafts. Microsurgery. 2012;32(5):358-363.
38.
De Stefano ME, Toni F, D’Orazi V, et al. Therapeutic approaches enhancing peripheral nerve regeneration. Adv Biosci Biotechnol. 2013;4:53.
39.
Sun F, Zhou K, Mi WJ, Qiu JH. Combined use of decellularized allogeneic artery conduits with autologous transdifferentiated adipose-derived stem cells for facial nerve regeneration in rats. Biomaterials. 2011;32(32):8118-8128.
40.
Wang X, Luo E, Li Y, Hu J. Schwann-like mesenchymal stem cells within vein graft facilitate facial nerve regeneration and remyelination. Brain Res. 2011;1383:71-80.
41.
Lundborg G, Dahlin LB, Danielsen N, et al. Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol. 1982;76(2):361-375.
42.
Williams LR, Powell HC, Lundborg G, Varon S. Competence of nerve tissue as distal insert promoting nerve regeneration in a silicone chamber. Brain Res. 1984;293(2):201-211.
43.
Timmer M, Robben S, MuIIer-Ostermeyer F, et al. AxonaI regeneration across long gaps in silicone chambers filled with Schwann cells overexpressing high molecular weight FGF-2. Cell Transplant. 2003;12(3):265-277.
44.
Lundborg G, Dahlin LB, Danielsen NP, Hansson HA, Larsson K. Reorganization and orientation of regenerating nerve fibres, perineurium, and epineurium in preformed mesothelial tubes - an experimental study on the sciatic nerve of rats. J Neurosci Res. 1981;6(3):265-281.
45.
Lundborg G, Dahlin L, Dohi D, Kanje M, Terada N. A new type of “bioartificial” nerve graft for bridging extended defects in nerves. J Hand Surg Br. 1997;22(3):299-303.10.1016/S0266-7681(97)80390-7
46.
Wangensteen KJ, Kalliainen LK. Collagen tube conduits in peripheral nerve repair: a retrospective analysis. Hand. 2010;5(3):273-277.
47.
Riccio M, Pangrazi PP, Parodi PC, et al. The amnion muscle combined graft (AMCG) conduits: a new alternative in the repair of wide substance loss of peripheral nerves. Microsurgery. 2014;34(8):616-622.
48.
Zhang P, Xue F, Kou Y, et al. The experimental study of absorbable chitin conduit for bridging peripheral nerve defect with nerve fasciculu in rats. Artif Cells Blood Substit Immobil Biotechnol. 2008;36(4):360-371.
49.
Wang W, Itoh S, Matsuda A, et al. Enhanced nerve regeneration through a bilayered chitosan tube: the effect of introduction of glycine spacer into the CYIGSR sequence. J Biomed Mater Res A. 2008;85(4):919-928.
50.
Xie F, Li QF, Gu B, Liu K, Shen GX. In vitro and in vivo evaluation of a biodegradable chitosan-PLA composite peripheral nerve guide conduit material. Microsurgery. 2008;28(6):471-479.
51.
Rosen JM, Padilla JA, Nguyen KD, Padilla MA, Sabelman EE, Pham HN. Artificial nerve graft using collagen as an extracellular matrix for nerve repair compared with sutured autograft in a rat model. Ann Plast Surg. 1990;25(5):375-387.
52.
den Dunnen WF, van der Lei B, Schakenraad JM, et al. Poly(DL-lactide-epsilon-caprolactone) nerve guides perform better than autologous nerve grafts. Microsurgery. 1996;17(7):348-357.
DOI
53.
Gonzalez-Perez F, Udina E, Navarro X. Extracellular matrix components in peripheral nerve regeneration. Int Rev Neurobiol. 2013;108:257-275.
54.
Brown RE, Erdmann D, Lyons SF, Suchy H. The use of cultured Schwann cells in nerve repair in a rabbit hind-limb model. J Reconstr Microsurg. 1996;12(3):149-152.
55.
Rodrigues MC, Rodrigues AA Jr, Glover LE, Voltarelli J, Borlongan CV. Peripheral nerve repair with cultured Schwann cells: getting closer to the clinics. Sci World J. 2012;2012:413091.
56.
Gordon T. Neurotrophic factor expression in denervated motor and sensory Schwann cells: relevance to specificity of peripheral nerve regeneration. Exp Neurol. 2014;254:99.
57.
Koudehi MF, Fooladi AA, Mansoori K, Jamalpoor Z, Amiri A, Nourani MR. Preparation and evaluation of novel nano-bioglass/gelatin conduit for peripheral nerve regeneration. J Mater Sci Mater Med. 2014;25(2):363-373.
58.
Lee JY, Giusti G, Friedrich PF, et al. The effect of collagen nerve conduits filled with collagen-glycosaminoglycan matrix on peripheral motor nerve regeneration in a rat model. J Bone Joint Surg Am. 2012;94(22):2084-2091.
59.
Gu J, Hu W, Deng A, Zhao Q, Lu S, Gu X. Surgical repair of a 30 mm long human median nerve defect in the distal forearm by implantation of a chitosan-PGA nerve guidance conduit. J Tissue Eng Regen Med. 2012;6(2):163-168.
60.
Ignatiadis IA, Yiannakopoulos CK, Avram AM, Gerostathopoulos NE. Posttraumatic neuroma of the radial nerve treated with an autogenous epineural conduit technique. A case report. Microsurgery. 2009;29(2):133-135.
61.
Tseng CY, Hu G, Ambron RT, Chiu DTW. Histologic analysis of Schwann cell migration and peripheral nerve regeneration in the autogenous venous nerve conduit (AVNC). J Reconstr Microsurg. 2003;19(5):331-340.
62.
Kehoe S, Zhang XF, Boyd D. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy. Injury. 2012;43(5):553-572.
63.
Battiston B, Geuna S, Ferrero M, Tos P. Nerve repair by means of tubulization: literature review and personal clinical experience comparing biological and synthetic conduits for sensory nerve repair. Microsurgery. 2005;25(4):258-267.
Publication history
Copyright
Rights and permissions

Publication history

Published: 14 December 2016
Issue date: December 2016

Copyright

© 2016 The Author(s).

Rights and permissions

© 2016 Ao. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

Return